Pharmacovigilance is increasingly adopted across pharmaceutical companies, regulatory bodies, clinical research organizations ...

Despite enormous progress in the past two decades, the intentional control of bionic prostheses remains a challenge and the ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

-- SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients -- WALTHAM, Mass., Oct. 21, 2025 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio ...

Good day, ladies and gentlemen, and welcome to today's GRAIL analyst call. [Operator Instructions] Please be advised that this conference call is being recorded. GRAIL Investor Relations. Please begin ...

Oracle Health and Life Sciences Executive Vice President and General Manager Seema Verma said Tuesday that artificial intelligence may be the key to closing the gap between administering quality ...

Researchers have developed a new method that greatly improves the accuracy of brain-state classification with functional near ...

Investor-focused update underscores enrollment momentum, biomarker strategy, and near-term data readouts designed to de-risk development of (Z)-Endoxifen and other endocrine therapies for DCIS SEATTLE ...

Immunocore reports third quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $103.7 million in ...